Navigation Links
Oligomerix, Inc. Completes Series B Financing
Date:5/22/2013

NEW YORK, May 22, 2013 /PRNewswire/ -- Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders, announced today the completion of its Series B financing, which includes both issuance of new convertible preferred shares and warrants that would represent approximately $2.8M in new investments in the Company.  Both current investors and new investors supported the raise.

Funding from the Series B round will allow Oligomerix to rapidly advance its drug discovery programs targeting tau protein oligomers that have recently been shown to be neurotoxic, impair memory formation and cause disease progression in disease models.  The Company is developing small molecule inhibitors of tau oligomer formation and antibodies specific for tau oligomer structure that have potential biomarker, diagnostic and therapeutic applications.  Oligomerix has discovered that tau becomes a proteolytic enzyme upon forming an oligomer structure that causes it and other proteins to fragment.  Based on this unique mechanistic insight into the toxicity of tau oligomers, Oligomerix is developing small molecule inhibitors of this activity and antibodies specific for tau's self-cut ends for biomarker and therapeutic uses.

James Moe , Ph.D., MBA, president and CEO of Oligomerix, Inc., commented, "We are pleased that our investors continue to believe in the breakthrough research Oligomerix is conducting across our core programs and that we have several new investors participating in this round.  We have demonstrated ongoing key developments in both our tau aggregation inhibitor and tau protease small molecule programs as well as in developing novel antibodies for each program.  Our research has shown that extracellular tau oligomers impair me
'/>"/>

SOURCE Oligomerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
2. Leviticus Cardio Ltd. Completes a Successful Animal Trial for its Wireless Energy System for VADs
3. St. Mary Completes Phase 2 of Its Emergency Department and Trauma Center Expansion
4. Centene Corporation Completes Acquisition Of Specialty Pharmacy Leader AcariaHealth
5. bioRASI Completes Acquisition of Ukrainian CRO
6. Novira Therapeutics Completes $25 Million Series A Financing
7. BGI-Shenzhen Completes Acquisition of Complete Genomics
8. Amarantus Completes Name Change and CUSIP Change
9. Advanced Cell Diagnostics Completes $12 Million Series B Financing
10. Synthetic Biologics Completes $10.8 Million Private Placement Financing
11. Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Palls Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... SILVER SPRING, Md. , Dec. 24, 2014 ... ) announced today that Medtronic, Inc. (NYSE: ... application to the U.S. Food and Drug Administration ... II implantable drug infusion system (including a ... Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... GMO corn cases filed across the ... in the process of being consolidated in a Kansas ... In Re: Syngenta AG MIR 162 Corn Litigation, MDL ... District of Kansas. , Management of the Syngenta GMO ... U.S. District Judge John W. Lungstrum.* , As a ...
(Date:12/24/2014)... 23, 2014 The report ... as its definition, classification, application and industry ... manufacturing process, and product cost structure. Production ... The analysis also covers upstream raw materials, ... development trend and proposals. In the end, ...
(Date:12/24/2014)... 2014 Vermillion, Inc. (Nasdaq:   VRML), ... announced today that investors including Oracle Investment Management, ... and several Vermillion directors have agreed to purchase ... common stock and warrants to purchase unregistered shares ... Under the terms of the ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... NxStage Medical, Inc.,(Nasdaq: NXTM ), a ... it has signed a five-year agreement with DaVita, ... DaVita,s dialysis centers with,MasterGuard and ButtonHole safety needle ... are essential products used to access patients,blood during ...
... Wins for Industry Leadership, JOPLIN, Mo., Jan. ... announced its Medical Power group has received,Battery Power ... received honors in the Industry Leadership category for ... battery., The Innova Award recognizes companies that ...
... NATICK, Mass., Jan. 7 Boston Scientific,Corporation (NYSE: ... sale of,its Cardiac Surgery and Vascular Surgery businesses to ... The sale follows the definitive agreement,announced on November 5, ... of approximately $240,million in connection with the transaction. These ...
Cached Biology Technology:NxStage Medical Announces Needle Supply Agreement with DaVita 2EaglePicher Technologies Receives Battery Power Products and Technology's First Annual Innova Award 2Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses 2Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses 3
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
(Date:12/4/2014)... PALM BEACH GARDENS, Fla. , Dec. 3, ... identity management solutions, today announced that its DigitalPersona ... 4500 fingerprint readers have been deployed throughout ... Carolina , South Carolina ... network headquartered in Southern Pines, North ...
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... New York College, and one of the most prolific ... signals that are transmitted from Smartphones to third party ... Smartphones and has one of the earliest known patents ... its usage in the military, child care, elder care ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
... cell divides into two daughter cells and those two cells ... so on, the result, biologists have long assumed, is an ... age -- at least not in the same way all ... biologists at the University of California, San Diego questions that ...
... change on the world,s land and sea will become more ... of a new book, the impacts of this change will ... natural resources for their livelihoods, but much can be done ... face of climate change. The book -- titled ...
... (Oct 27, 2011)Researchers have built a map that shows how ... each other . This is the largest and most ... approximately 5000, or one third, of the proteins cooperate to ... decades, trying to unravel the precise connections among the proteins ...
Cached Biology News:Do bacteria age? Biologists discover the answer follows simple economics 2Do bacteria age? Biologists discover the answer follows simple economics 3New book proposes solutions to social and ecological challenges posed by climate change 2New book proposes solutions to social and ecological challenges posed by climate change 3Researchers build largest protein interaction map to date 2Researchers build largest protein interaction map to date 3
Cell Culture Flask, 75 cm, treated polystyrene...
Cell Culture Flask, 75 cm, nontreated polystyrene...
... In virtually every research laboratory, the ... of information accurately, inexpensively and in real ... compact lab analysis system includes the Luminex ... It utilizes xMAP technology which enables you ...
... Analysis of large numbers of samples may ... gradient system, which requires minimum operator attention. ... by PowerStream software and interface CE 4900. ... software operates in Windows XP and Windows 98 ...
Biology Products: